Targa Resources TRGP 深 滬
已收盤 10-16 16:00:00 美东时间
294.90
+12.350
+4.37%
華盛通- 最 高295.12
- 今 開285.85
- 成交量 111.09万股
- 最 低 285.475
- 昨 收 282.55
- 總市值 632.36亿
- 52周最高 307.94
- 市盈率 靜 34.74
- 換手率 0.52%
- 52周最低 145.50
- 委 比 46.88%
- 總股本 2.14亿
- 歷史最高 307.94
- 量 比 1.33
- 振 幅 3.41%
- 歷史最低 -14.66
- 每 手 1
- 風險率 45.82%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Targa Resources Corp收涨4.37%，成交额3.24亿美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 04:36
Targa Resources declares $1.25 dividend
Targa Resources (TRGP) declares $1.25/share quarterly dividend, in line with previous. Forward yield 1.71% Payable Nov. 17; for shareholders of record Oct. 30; ex-div Oct. 30. See TRGP Dividend Scorec...
10-14 12:58
美股大行评级 | 潜在涨幅179.23%！奥本海默上调Aurora Innovation目标价至16美元，维持"跑赢大市"评级
今日重点评级关注：奥本海默：维持Aurora Innovation"跑赢大市"评级，目标价从15美元升至16美元；富国银行：维持Applied Digital"超配"评级，目标价从50美元升至55美元
10-09 16:25
Barclays Maintains Overweight on Targa Resources, Raises Price Target to $294
Barclays analyst Theresa Chen maintains Targa Resources (NYSE:TRGP) with a Overweight and raises the price target from $284 to $294.
10-08 23:51
Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces Its Net Asset Value and Asset Coverage Ratios as of September 30, 2026
Kayne Anderson Energy Infrastructure Fund, Inc. reported net assets of $2.6 billion and a net asset value per share of $15.42 as of September 30, 2026. The company's asset coverage ratios under the 1940 Act were 589% for senior securities and 471% for total leverage. The portfolio is primarily invested in Midstream Energy Companies (98%), with the top ten holdings including Energy Transfer LP, Cheniere Energy, Inc., and Enterprise Products Partne...
10-01 22:25
美股夜盘 | 阿克迈暴升20.72%，Chime Financial小升3.44%
阿克迈暴升20.72%；Chime Financial小升3.44%；三菱日联金融小升2.26%
09-25 09:01
美股盘后 | IonQ Inc暴升11.14%，Permian Resources上升3.17%
IonQ Inc暴升11.14%；Permian Resources上升3.17%；Quantinuum上升2.80%
09-23 06:10
美股大行评级 | 麦当劳目标价遭下调至320美元！现价仍有近3成上涨空间；戴尔、迈威尔、微软齐获机构看好
今日重点评级关注：HC Wainwright & Co.：维持Gossamer Bio"买入"评级，目标价从2美元升至90美元；巴克莱：维持Ultragenyx Pharmaceutical"超配"评级，目标价从32美元升至35美元
09-22 16:25
